The center combines specialist expertise, advanced imaging, and modern infrastructure, with access to large and diverse patient populations, enabling efficient and high-quality clinical studies.

It enables early access to new treatments while strengthening Sweden’s role in advancing future eye care.

“With this center, we are taking an important step forward for patients with eye diseases. It enables early access to new treatments while strengthening Sweden’s role in advancing future eye care,” says Sten Kjellström, Hospital Director, St. Erik Eye Hospital.

End-to-end study support

The facility provides end-to-end study support, including sample collection, data capture, and quality assurance, integrated within routine care to facilitate participation.

“We have created a coordinated structure with clear processes from first contact to study completion. Our focus is rapid start-up, high data quality, and smooth study execution,” says Gauti Jóhannesson, Chief Physician and Head of Research.

Collaboration with Karolinska Institutet

The collaboration with Karolinska Institutet links clinical operations to leading research in vision science.

“Diagnostics and treatments in ophthalmology are advancing rapidly, driven by AI-based image analysis, alongside the development of cell and gene therapies and novel drug delivery technologies,” says Carl-Johan Sundberg, Dean at Karolinska Institutet.

The initiative is part of the Stockholm Region’s broader investment in research and innovation, aimed at increasing clinical trial capacity and improving patient access to new therapies.